Nadined Tosk News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nadined tosk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nadined Tosk Today - Breaking & Trending Today
Pulse Biosciences Receives FDA 510(k) Clearance of Expanded Energy Settings for use with the CellFX® System streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Pulse Biosciences, Inc. Announces the Closing of Its Rights Offering streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
(2) Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation (NPS) technology, today announced that the first CellFX procedures in the European Union were successfully completed. The initial commercial use of the non-thermal, cellular-focused CellFX System to clear common benign lesions, now expands the Company s controlled launch program starting with the top aesthetic dermatologists and plastic surgeons across Europe. This strategic rollout in Europe will run in parallel with the Company s U.S. controlled launch aimed at building a strong foundation of clinical and commercial advocacy as the Company grows a promising global business. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210219005136/en/ ....
Press release content from Business Wire. The AP news staff was not involved in its creation. Pulse Biosciences Announces First CellFX Procedures Performed in Europe as Part of Global Controlled Launch February 19, 2021 GMT HAYWARD, Calif. (BUSINESS WIRE) Feb 19, 2021 Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced that the first CellFX ® procedures in the European Union were successfully completed. The initial commercial use of the non-thermal, cellular-focused CellFX System to clear common benign lesions, now expands the Company’s controlled launch program starting with the top aesthetic dermatologists and plastic surgeons across Europe. This strategic rollout in Europe will run in parallel with the Company’s U.S. controlled launch aimed at building a strong foundation of clinical and commercial advocacy as the Company grows a promising global business. ....